Xbryk Alternatives Compared
| Xbryk (denosumab) | Zometa (zoledronic acid) | Sensipar (cinacalcet) |
|
|---|
| Xbryk (denosumab) | Zometa (zoledronic acid) | Sensipar (cinacalcet) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Osteolytic Bone Metastases of Solid Tumors, Giant Cell Tumor of Bone, Osteolytic Bone Lesions of Multiple Myeloma, Hypercalcemia of Malignancy. Xbryk may also be used for purposes not... View more |
Prescription only
Zometa is only available as an injection for administration by a healthcare provider and is indicated for the treatment of hypercalcemia associated with cancer, osteolytic bone lesions of multiple... View more |
Prescription only
Prescribed for Primary Hyperparathyroidism, Secondary Hyperparathyroidism, Hypercalcemia of Malignancy. Sensipar may also be used for purposes not listed in this medication guide. |
Related suggestions Hypercalcemia of Malignancy
|
|||||||
| More about (denosumab) | More about Zometa (zoledronic acid) | More about Sensipar (cinacalcet) | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Zometa has an average rating of 4.8 out of 10 from a total of 44 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 50% reported a negative effect. |
Sensipar has an average rating of 5.7 out of 10 from a total of 9 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Xbryk side effects |
View all Zometa side effects |
View all Sensipar side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic approved | Lower cost generic approved | ||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Sensipar prices |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Other denosumab brands include: Bomyntra, Conexxence, Jubbonti, Osenvelt, Ospomyv, Prolia, Stoboclo, Wyost, Xgeva View more | Other zoledronic acid brands include: Aclasta, Reclast |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
609.6 hours |
N/A |
40 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 307 drugs are known to interact with Xbryk:
|
A total of 123 drugs are known to interact with Zometa:
|
A total of 158 drugs are known to interact with Sensipar:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
N/A |
February 22, 2002 |
March 08, 2004 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
|
N/A |
||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Dexamethasone Intensol
Dexamethasone Intensol is used for addison's disease, adrenal insufficiency, adrenocortical ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Xgeva
Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is ...
Sensipar
Sensipar reduces elevated levels of parathyroid hormone in people with chronic renal disease who ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.